DOI QR코드

DOI QR Code

Oyster mushroom extract protects antioxidant defence system in cisplatin induced nephrotoxicity in mice

  • 발행 : 2004.03.30

초록

Cisplatin is a highly effective and extensively used anticancer drug. Higher doses of cisplatin manifest acute nephrotoxicity and this is one of the limiting factors of this drug in cancer chemotherapy. The effect of the oyster mushroom extract to ameliorate cisplatin ( cis platinum (II) diammine dichloride) induced nephrotoxicity and restoration of antioxidant defence system in mice was investigated. The investigations showed that prior administration of methanolic extract of Pleurotus florida at a dose of 500 and 1000mg/Kg body weight significantly reduced elevated serum creatinine and urea levels and increased superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) activities in the kidney, consequent to cisplatin treatment, in a dose dependent manner. The extract restored the decreased reduced glutathione (GSH) activity and increased malondialdehyde (MDA) level due to cisplatin administration. The results thus indicated that oyster mushroom extract rendered significant protection against cisplatin induced nephrotoxicity and depletion of antioxidant defence system in a dose dependent manner. Since oyster mushrooms are excellently edible and non-toxic, the finding reported here is of significant use in cancer chemotherapy.

키워드

참고문헌

  1. Aebi H. (1974) In Methods in EnzymaticAnalysis. Vol 2. edited by Bergemeyer HU pp. 673-675. Academic Press Inc., New York.
  2. Ajith TA, Jose N, Janardhanan KK. (2000) Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus Phellinus rimosus. J. Exp. Clin. Cancer Res. 21, 213-217.
  3. Babu EV, Gopalkrishnan VK, Sriganth NP, Gopalkrislman R, Sakthisekaran D. (1995) Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol. Cell Biochem. 144, 7-11. https://doi.org/10.1007/BF00926734
  4. Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF. (1986) Selective protection against cisplatin induced toxicity in kidney, gut, and bone marrow by DDTC. Cancer Res. 46, 2751-2755.
  5. Boogaard PJ, Lempers EL, Mulder GJ, Meerman JHN. (1991) 4- Methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising antitumor activity. Biochem. Pharmacol. 41, 1997-2003. https://doi.org/10.1016/0006-2952(91)90141-Q
  6. Brod J, Sirota JH. (1980) In Methods of Practical clinical Biochemistry. Vol 1, edited by Varley H, Gowenlock AH, Bell M, pp. 478-480, Heinnmann, London.
  7. Chang, R. (1996) Functional properties of edible mushrooms. Nutr. Rev. 45 (II), 91-93.
  8. Cozzaglio I, Doci R, Colla G, Zunino F, Casciarri G, Gennari L. (1990) A feasibility study of high dose cisplatin and 5-fluorouracil with glutathione protection in the treatment of advanced colorectal cancer. Tumori. 76, 590-594.
  9. Dubois M., Gilles GA, Hamiliton JK. (1956) Colorimetric estimation of carbohydrates by phenol-sulphuric acid method. Ann. Chem. 28, 350-356. https://doi.org/10.1021/ac60111a017
  10. Hannemann J., Baumann K. (1988) Cisplatin induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicol. 51, 119-132. https://doi.org/10.1016/0300-483X(88)90143-6
  11. Hafemann DG, Sunde RA, Houestra WG. (1974). Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104, 580-583. https://doi.org/10.1093/jn/104.5.580
  12. Hamers FPT, Brakkee JH, Cavalletti E, Tedeschi M, Marmonti L, Pezzoni G, Neijt JP, Gispen WH. (1993) Reduced Glutathione protects against cisplatin induced toxicity in rats. Cancer Res. 53, 544-549.
  13. Harbone JB. (1973) Phytochemical Methods. pp 33-80. Chapman and Hall Ltd., London.
  14. Jose N, Janardhanan KK. (2000) Antioxidant and antitumor activity of Pleurotus florida. Curr. Sci. 79, 941-943.
  15. Lowry HD, Rosenbrough NJ, Farr AL, Randa RJ. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275.
  16. Marshell MH, Fingerhut B, Miller H. (1980) Methods of practical clinical Biochemistry. vol 1, edited by Varley H, Gowenlock AH, Bell M. pp. 456-460, Heinnmann London.
  17. Mc Cord, JM, Fridovich I. (1969) Superoxide dismutase, an enzymatic function for erythrocuprein. J. Biol. Chem. 244, 6049-6055.
  18. Moron MA, De Pierre JW, Mannervick B. (1979) Levels of Glutathione, Glutathione reductase, Glutathione S transferase activities in rat liver. Bichem. Biophys. Acta 67, 582-586.
  19. Ohkawa H, Ohishi N, Yagi K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 51-358 .
  20. Sinet, PM., Carber P. (1981) Inactivation of the human Cu Zn Superoxide dismutase during exposure to $O_2$ and $H_2O_2$. Arch. Biochem. Biophys. 212, 411- 416. https://doi.org/10.1016/0003-9861(81)90382-9
  21. Somani SM, Huzain K, Whitvvorth C, Trammall LG, Malafa M, Ryback PL. (2000) Dose dependent protection by lipoic acid against cisplatin induced nephrotoxicity in rats:Antioxidant defense system. Pharmacol. Toxicol. 86, 234-241. https://doi.org/10.1034/j.1600-0773.2000.d01-41.x
  22. Tognella, S. (1990) Pharmacological interventions to reduce platinum induced toxicity. Cancer Treat Rev. 17, 139-142. https://doi.org/10.1016/0305-7372(90)90038-H
  23. Yemm EW, Wills AJ. (1954) The estimation of carbohydrate in plant extract by anthrone. Biochem. J. 57, 508-514. https://doi.org/10.1042/bj0570508